Desvenlafaxine Production Cost Reports

The report provides a detailed analysis essential for establishing a desvenlafaxine production plant. It encompasses all critical aspects necessary for desvenlafaxine production, including the cost of desvenlafaxine production, desvenlafaxine plant cost, desvenlafaxine production costs, and the overall desvenlafaxine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a desvenlafaxine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Desvenlafaxine is a pharmaceutical compound mainly used in the treatment of mental health conditions. It is most commonly prescribed for managing major depressive disorder in adults, where it helps improve mood, energy levels, and overall sense of well-being. It works by increasing the levels of certain natural chemicals in the brain, such as serotonin and norepinephrine, which play a major role in mood regulation.

It is also sometimes used for the treatment of anxiety disorders and menopausal symptoms like hot flashes. It is primarily prescribed as an antidepressant for the treatment of major depressive disorder. It is taken orally and is designed for long-term use under medical supervision. It is also utilised in clinical research related to mental health disorders, including anxiety and stress-related conditions. In addition, the compound also plays an important role in the development of combination therapies and generic medicines.

The market for desvenlafaxine is primarily driven by its application as a drug for the treatment of psychiatric disorders in adults, which boosts its demand in the medical sector. Its application as an effective serotonin-norepinephrine reuptake inhibitor (SNRI) in the treatment of major depressive disorder (MDD) significantly strengthens its demand in the medical and healthcare industries.

Its usage as an important ingredient in the development of modern psychiatric treatment options also supports its demand in the pharmaceutical production industry. Its application in managing anxiety and menopausal symptoms, such as hot flashes, further supports its demand in the global pharmaceutical and healthcare industries. Industrial Desvenlafaxine procurement is influenced by several key factors, including the cost and availability of active pharmaceutical ingredients (APIs), compliance with health regulations, and adherence to Good Manufacturing Practices (GMP). Furthermore, advancements in drug formulation, reliable supply chains, evolving treatment guidelines, and a rising preference for extended-release dosage forms also play a crucial role in shaping procurement strategies across various global markets.

Raw Material for Desvenlafaxine Production

According to the desvenlafaxine production plant project report, the major raw materials for desvenlafaxine production include L-selectride, Venlafaxine, Succinic Acid; 4-benzyloxyphenylacetic acid, thionyl chloride, dimethylamine, LHMDS (lithium hexamethyldisilazide), and Cyclohexanone.

Production Processes of Desvenlafaxine

The extensive desvenlafaxine production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of desvenlafaxine begins with the demethylation of venlafaxine using L-selectride in dimethoxyethane to form desvenlafaxine as a free base. Then, the obtained base compound is recrystallised with succinic acid in an acetone-water mixture to form desvenlafaxine succinate.
    
2. Production from 4-Benzyloxyphenylacetic Acid: The production process of desvenlafaxine starts with 4-benzyloxyphenylacetic acid, which is converted to an acid chloride using thionyl chloride and then reacted with dimethylamine to form a dimethylacetamide intermediate. Then, this intermediate is treated with LHMDS and reacted with cyclohexanone to produce an alcohol, which is further reduced with borane to form a dimethylamine compound. Finally, the obtained compound is debenzylated through catalytic hydrogenation with Pd/C to obtain desvenlafaxine as the desired product.

Desvenlafaxine is a synthetic phenethylamine derivative and the O-desmethylated active metabolite of venlafaxine. It belongs to the serotonin-norepinephrine reuptake inhibitor (SNRI) class of antidepressants. It appears as a white to off-white crystalline powder in its salt forms. The molecular formula of the compound is C16H25NO2, and its molar mass is 263.38 g/mol. The compound possesses two hydrogen bond donors and three hydrogen bond acceptors, which contribute to its pharmacokinetic characteristics. Its commonly used salt form is desvenlafaxine succinate, which exhibits pH-dependent solubility and is soluble in water. It has an octanol-to-aqueous partition coefficient of 0.21 at pH 7.0, which indicates its hydrophilic nature. It is generally stored at 4 degree Celsius. The compound demonstrates an absolute oral bioavailability of approximately 80%. The compound should be used under medical supervision, and abrupt discontinuation may lead to withdrawal symptoms. Therefore, gradual dose reduction is recommended when stopping therapy.